SCHEMBL8273684

SCHEMBL8273684

BN1CCCC1Cc1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHI3L1 P36222 3/20 0.46
KCNH2 Q12809 4/20 0.43
CHIT1 Q13231 4/20 0.43
CHIA Q9BZP6 4/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.42
HRH3 Q9Y5N1 1/20 0.40
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
SPHK2 Q9NRA0 1/20 0.39
SPHK1 Q9NYA1 1/20 0.39
TRPV6 Q9H1D0 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA5 P30532 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21732238 0.85 ALDH1A1 (0.38) KCNH2CHIT1CHIAALDH1A1KDM4E
SCHEMBL11369857 0.79 CHRNB2 (0.54) CHI3L1KCNH2HRH3CHRNB2CHRNA5
SCHEMBL11371632 0.76 CHI3L1 (0.43) CHI3L1KCNH2CHIT1CHIAALDH1A1
SCHEMBL11372466 0.76 CHI3L1 (0.43) CHI3L1KCNH2CHIT1CHIAALDH1A1
SCHEMBL19786306 0.75 LTA4H (0.38) CHI3L1HRH3
SCHEMBL4278447 0.75 CHRNB2 (0.49) KCNH2CHIT1CHIAALDH1A1KDM4E
SCHEMBL11486228 0.73 CHRNB2 (0.48) KCNH2CHIT1CHIAALDH1A1KDM4E
SCHEMBL11486276 0.73 ALDH1A1 (0.51) KCNH2CHIT1CHIAALDH1A1KDM4E
SCHEMBL11370283 0.73 CHI3L1 (0.42) CHI3L1KCNH2CHIT1CHIAALDH1A1
SCHEMBL11469767 0.72 CHIT1 (0.60) CHI3L1KCNH2CHIT1CHIAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006002004-A1 PYRROLIDIN-3-YL COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2006-01-05 WO disclosed